Scoring system to predict DIC in newborns
Part of Blood & lymphatic clinical trials.
This study tests a scoring system to help predict the severity of disseminated intravascular coagulation (DIC), a serious blood clotting disorder, in newborns. It aims to find better ways to identify babies who need early treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 1 and 28 days old.
- Your baby must have been diagnosed with DIC (a condition where blood clots and bleeding happen at the same time).
- Your baby cannot have a mother who has ITP (a condition that causes low platelets).
- Your baby cannot have autoimmune low platelets themselves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a clotting problem called DIC affects the risk of death in children with shock. It may help doctors better predict and manage these serious conditions.
This study looks for early signs of dangerous blood clotting complications (called DIC) in patients admitted to intensive care with severe infection. Finding these signs early may help doctors treat the problem faster and improve outcomes.
This study measures a type of white blood cell (neutrophil) fluorescence in patients with septic shock who also have a serious blood clotting condition called disseminated intravascular coagulation (DIC). The goal is to see if this measurement can help doctors better understand or manage the condition.
This study looks at how very low platelet levels (and platelet transfusions, if needed) affect bleeding and inflammation in newborns. It may help doctors better understand which newborns are at higher risk and how to manage low platelets.
This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
Hear when a new Disseminated Intravascular Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.